Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by 8methoxypsoralen Or 5 Methoxypsoralen

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Completed1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • 8methoxypsoralen Or 5 Methoxypsoralen1
  • 8methoxypsoralen Or 5methoxypsoralen1

Active Sponsors

  • Innovaderm Research Inc.1
  • Medical University of Vienna1

Top Investigators

Related Conditions

  • Nonpustular Palmoplantar Psoriasis1
  • Lower Leg Psoriasis1
  • Scalp Psoriasis1
  • Elbow Psoriasis1

Activity Timeline